Abstract
The β-chemokines MIP-1α, MIP-1β and RANTES inhibit infection of CD4+ cells by primary, non-syncytium-inducing (NSI) HIV-1 strains at the virus entry stage, and also block env-mediated cell–cell membrane fusion. CD4+ T cells from some HIV-1-exposed uninfected individuals cannot fuse with NSI HIV-1 strains and secrete high levels of β-chemokines. Expression of the β-chemokine receptor CC-CKR-5 in CD4+ , non-permissive human and non-human cells renders them susceptible to infection by NSI strains, and allows env-mediated membrane fusion. CC-CKR-5 is a second receptor for NSI primary viruses.
References
Levy, J. A., Mackewicz, C. E. & Barker, E. Immun. Today 17, 217–224 (1996).
Coochi, F. et al. Science 270, 1811–1815 (1995).
Paxton, W. A. et al. Nature Med. 2, 412–417 (1996).
Neote, K., DiGregorio, D., Mak, J. Y. Horuk, R. & Schall, T. J. Cell 72, 415–425 (1993).
Gao, J.-L. et al. J. exp. Med. 177, 1421–1427 (1993).
Bacon, K. B., Premack, B. A., Gardner, P. & Schall, T. J. Science 269, 1727–1729 (1995).
Raport, C. J. et al. J. Leuk. Biol. 59, 18–23 (1996).
Wells, T. N. C. et al. J. Leuk. Biol. 59, 53–60 (1996).
Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. Science 272, 872–877 (1996).
Chen, B. K., Saksela, K., Andino, R. & Baltimore, D. J. Virol. 68, 654–660 (1994).
Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. Virology 206, 935–944 (1995).
Lusso, P. et al. J. Virol. 69, 3712–3720 (1995).
Charo, I. F. et al. Proc. natn. Acad. Sci. U.S.A. 91, 2752–2756 (1994).
Ben-Baruch, A. et al. J. biol. Chem. 270, 22123–22128 (1995).
Combadiere, C. et al. J. biol. Chem. 270, 29671–29675 (1995).
Litwin, V. et al. J. Virol. (in the press).
Moore, J. P., Jameson, B. A., Weiss, R. A. & Sattentau, Q. J. in Viral Fusion Mechanisms (ed. Bentz, J.) 233–289 (CRC Press, Boca Raton, FL, 1993).
Maddon, P. J. et al. Cell 47, 333–348 (1986).
Ashorn, P. A., Berger, E. A. & Moss, B. J. Virol. 64, 2149–2156 (1990).
Clapham, P. R., Blanc, D. & Weiss, R. A. Virology 181, 703–715 (1991).
Samson, M., Labbe, O., Mollereau, C., Vassart, G. & Parmentier, M. Biochemistry 11, 3362–3367 (1996).
Dragic, T., Charneau, P., Clavel, F. & Alizon, M. J. Virol. 66, 4794–4802 (1992).
Loetscher, M. et al. J. biol. Chem. 269, 232–237 (1994).
Chaudhuri, A. et al. J. biol. Chem. 269, 7835–7838 (1994).
Neote, K., Mak, J. Y., Kolakowski, L. F. Jr & Schall, T. J. Blood 84, 44–52 (1994).
Dragic, T., Picard, L. & Alizon, M. J. Virol. 69, 1013–1018 (1995).
Puri, A., Morris, S. J., Jones, P., Ryan, M. & Blumenthal, R. Virology 219, 262–267 (1996).
Connor, R. I. & Ho, D. D. J. Virol. 68, 4400–4408 (1994).
Moore, J. P. & Ho, D. D. AIDS 9 (suppl. A), S117–S136 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dragic, T., Litwin, V., Allaway, G. et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667–673 (1996). https://doi.org/10.1038/381667a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/381667a0
This article is cited by
-
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection
Retrovirology (2022)
-
COVID-19 2022 update: transition of the pandemic to the endemic phase
Human Genomics (2022)
-
A search for potential anti-HIV phytoconstituents from the natural product repository
Advances in Traditional Medicine (2022)
-
Co-receptor signaling in the pathogenesis of neuroHIV
Retrovirology (2021)
-
Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients
Gene Therapy (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
